- US stocks rose on Monday after AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%.
- This marks the third COVID-19 vaccine that surpassed the FDA’s stated threshold requirement of 50% effectiveness.
- Watch major indexes update live here.
US stocks gained on Monday as investor optimism surrounding the development of successful COVID-19 vaccine candidates remained elevated.
AstraZeneca said on Monday that its COVID-19 vaccine, developed in partnership with the University of Oxford, demonstrated an average efficacy rate of 70%. While one dosing regiment showed an efficacy rate of 90%, another dosing regiment demonstrated an efficacy rate of 62%.
This marks the third COVID-19 vaccine that has surpassed the FDA’s stated threshold for approval of at least 50% efficacy in preventing the virus, the others being from Pfizer and Moderna.
Here’s where US indexes stood shortly after the 9:30 a.m. ET market open on Monday:
- S&P 500: 3,580.82, up 0.7%
- Dow Jones industrial average: 29,473.41, up 0.7% (210 points)
- Nasdaq composite:11,929.04, up 0.6%
Americans could begin to receive COVID-19 vaccines as early as December 11, according to an Operation Warp Speed advisor. This could set up the country to hit herd immunity rates of 70% by May, suggesting life may get back to some levels of normality by next Summer.
Oil prices staged a rebound on Monday, hitting its highest levels since early September as positive vaccine news suggests demand for oil could come back sooner than later.
Bitcoin’s strong rally to above $US18,000 helped spur a surge in other cryptocurrency assets like Ethereum and Ripple over the weekend.
Gold declined as much as 0.5%, to $US1,862.64 per ounce.
Business Insider Emails & Alerts
Site highlights each day to your inbox.